Results 221 to 230 of about 2,913,789 (269)

Anti‐CD20 Discontinuation Versus Continuation in People Aged Over 50 With Non‐Active Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To determine whether discontinuing anti‐CD20 therapy in people with relapsing‐onset MS aged over 50 is associated with an increased risk of relapse, inflammatory activity, confirmed disability accrual, and serious infection compared with continuing therapy.
Alexia Moukhine   +40 more
wiley   +1 more source

Local Wealth Inequality and Working-Age Mortality in US Counties.

open access: yesJAMA Health Forum
Schechtl M   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy